Join
Live feed
·
INSIDERFilingvia Quantisnow
Milestone Pharmaceuticals Inc. logo

President and CEO Oliveto Joseph was granted 280,000 shares, sold $375,315 worth of shares (167,577 units at $2.24) and converted options into 66,600 shares, increasing direct ownership by 59% to 482,744 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MIST· Milestone Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIST (Milestone Pharmaceuticals Inc.) and more on Quantisnow.

President and CEO Oliveto Joseph was granted 280,000 shares, sold $375,315 worth of shares (167,577 units at $2.24) and converted options into 66,600 shares, increasing direct ownership by 59% to 482,744 units (SEC Form 4) | Quantisnow